Jonathan Tobin has been promoted to the position of managing director of Arix Bioscience Plc from investment director. He will also join the boards of the Arix portfolio companies VelosBio Inc, which is developing antibody-drug conjugates for cancer, and Depixus SAS, which is analysing the genomics of biological systems. Dr Tobin holds a PhD in molecular medicine from University College London, UK.
Arix Bioscience announced the appointments on 15 April 2020.
Copyright 2020 Evernow Publishing Ltd.